Skye Bioscience, Inc. (SKYE) shares outstanding

Shares outstanding · fiscal 2025
4.96M

Skye Bioscience, Inc. (SKYE) had 4.96M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 8.7% higher than the 4.56M of fiscal 2024. Figures as of 18 Nov 2026, 12:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
4.96M
Change on fiscal 2024
+8.7%
Growth, 5 years
+112.0% a year
Highest on record
4.96Mfiscal 2025
Lowest on record
9.47Kfiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Skye Bioscience, Inc. shares outstanding, in more detail

The market data feed counts 4.42M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 112.0% a year. Across the 10 fiscal years on record (2016–2025), the highest was 4.96M in fiscal 2025 and the lowest 9.47K in fiscal 2016.

History · 10 fiscal years

Shares outstanding by fiscal year

Skye Bioscience, Inc. shares outstanding, year by year

Skye Bioscience, Inc. (SKYE) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
20254.96M 8.7% up
20244.56M 420.8% up
2023875.75K 215.4% up
2022277.64K 36.6% up
2021203.30K 75.7% up
2020115.71K 36.5% up
201984.78K 40.0% up
201860.58K 334.2% up
201713.95K 47.3% up
20169.47K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on SKYE

Skye Bioscience, Inc., figure by figure

Skye Bioscience, Inc. (SKYE) overview: price, valuation and scorecard

Skye Bioscience, Inc. shares outstanding: questions and answers

How many shares does Skye Bioscience, Inc. have?

Skye Bioscience, Inc. (SKYE) had 4.96M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 8.7% higher than the 4.56M of fiscal 2024. The market data feed counts 4.42M shares outstanding today.

What is the growth rate of Skye Bioscience, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 112.0% a year.

What are the highest and lowest diluted share count figures on record for Skye Bioscience, Inc.?

Across the 10 fiscal years on record (2016–2025), the highest was 4.96M in fiscal 2025 and the lowest 9.47K in fiscal 2016.

How is Skye Bioscience, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Skye Bioscience, Inc. it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Skye Bioscience, Inc. (SKYE) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/SKYE/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.